Elizabeth A. Harker, Ph.D.
Affiliations: | 2009 | Yale University, New Haven, CT |
Area:
protein–protein and protein–DNA interactionsGoogle:
"Elizabeth Harker"Mean distance: 7.72 | S | N | B | C | P |
Parents
Sign in to add mentor| Alanna Schepartz | grad student | 2009 | Yale | |
| (Design and evaluation of beta3-peptide ligands for hDM2 and hDMX.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Michel J, Harker EA, Tirado-Rives J, et al. (2009) In Silico Improvement of beta3-peptide inhibitors of p53 x hDM2 and p53 x hDMX. Journal of the American Chemical Society. 131: 6356-7 |
| Harker EA, Schepartz A. (2009) Cell-permeable beta-peptide inhibitors of p53/hDM2 complexation. Chembiochem : a European Journal of Chemical Biology. 10: 990-3 |
| Harker EA, Daniels DS, Guarracino DA, et al. (2009) Beta-peptides with improved affinity for hDM2 and hDMX. Bioorganic & Medicinal Chemistry. 17: 2038-46 |
| Bautista AD, Craig CJ, Harker EA, et al. (2007) Sophistication of foldamer form and function in vitro and in vivo. Current Opinion in Chemical Biology. 11: 685-92 |
| Kritzer JA, Luedtke NW, Harker EA, et al. (2005) A rapid library screen for tailoring beta-peptide structure and function. Journal of the American Chemical Society. 127: 14584-5 |